Treatment of asthma with triamcinolone acetonide aerosol.

Chest
M H Williams

Abstract

Thirty-five steroid-dependent asthmatic patients have been treated with an aerosol of triamcinolone acetonide for periods ranging from 8 to 26 months. Fourteen patients discontinued the oral use of steroids for the first time in from 2 to 19 years and throughout the period of treatment with aerosol, have not required any other steroid medication. Fifteen patients were able to discontinue oral use of steroids but have required one or more short supplemental courses of oral steroid treatment for exacerbations of asthma. Six patients have either continued to require oral steroid therapy, or their symptoms have been incompletely controlled by the aerosol. Steroid aerosols represent an important advance for the treatment of asthma. Small doses which do not suppress adrenal function and do not produce hyperadrenocorticism make it possible for most patients to eliminate or substantially reduce their requirement for oral steroid therapy.

References


❮ Previous
Next ❯

Citations

Jun 12, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Kathleen Ververeli, Bradley Chipps
Jan 1, 1994·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·M J Welch
Jan 1, 1978·The Journal of Asthma Research·E Lee-Hong, C Collins-Williams
Jan 1, 1982·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·N Olivier
Jan 1, 1978·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·N Svedmyr, B G Simonsson
Jan 1, 1982·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·C J Falliers, A J Petraco
Nov 1, 1984·Pharmacotherapy·C S Tse, I L Bernstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.